Septerna, Inc. (SEPN) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -45.09%.
- 2026-03-31: Pre-Tax Margin -31.29%.
- 2025-12-31: Pre-Tax Margin -44.47%.
- 2025-09-30: Pre-Tax Margin 38.02%.
Complete source-backed pre-tax margin history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -45.09% |
| 2026-03-31 | -31.29% |
| 2025-12-31 | -44.47% |
| 2025-09-30 | 38.02% |
| 2025-06-30 | -20872.27% |
| 2025-03-31 | -9806.39% |
| 2024-12-31 | -9824.53% |
| 2024-09-30 | -11738.07% |
| 2024-06-30 | -4472.97% |
| 2024-03-31 | -4498.11% |
| 2023-12-31 | -15383.90% |
| 2023-09-30 | -33166.67% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -106.35% |
| 2024-12-31 | -6725.21% |
| 2023-12-31 | -32362.25% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |